Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
NCT 05911295 Brief Summary This study will enroll participants with urothelial cancer…
Read more arrow_forwardNCT 05911295 Brief Summary This study will enroll participants with urothelial cancer…
Read more arrow_forwardNCT 05598151 Brief Summary This is a Phase1 study to assess the…
Read more arrow_forwardNCT 02821013 Brief Summary The purpose of this study is to…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.